On the other hand, PAD is characterized by a tremendously favorable ischemic environment triggering VEGF production and an ample number of investigations have suggested that patients with PAD and coexisting diabetes display higher or at least unchanged serum levels of VEGF-A (Table 1) (13–20, 22–25). This evidence concerns the gene VEGFA and peripheral arterial disease.